Corporate Banner
Satellite Banner
Genotyping & Gene Expression
Scientific Community
Become a Member | Sign in
Home>News>This Article

Science for Life Laboratory Joins the Illumina Genome Network

Published: Monday, February 24, 2014
Last Updated: Monday, February 24, 2014
Bookmark and Share
First European Genome Network partner plans large scale population sequencing program.

Illumina, Inc. announce that Science for Life Laboratory (SciLifeLab) in Sweden has joined the Illumina Genome Network (IGN) to provide researchers with broader access to Illumina's whole genome sequencing technology. SciLifeLab is the first IGN partner in Europe and will initiate a national large-scale population sequencing program seeking to identify genetic causes of human diseases. 

"We now have the opportunity to offer an even larger capacity of high throughput sequencing to researchers from all over Sweden. In the research program we are about to launch, we aim to sequence more than 1,000 human genomes using the Illumina systems," said Joakim Lundeberg, Professor in Gene Technology at KTH Royal Institute of Technology and Director of the National Genomics Infrastructure at Science for Life Laboratory. 

"We are very excited to welcome the SciLifeLab to our prestigious group of IGN partners and to work with them on their groundbreaking national genome sequencing project," said Alex Dickinson, Senior Vice President Strategic Initiatives for Illumina. "We look forward to working with SciLifeLab to speed genetic discovery and establish a map of genetic variability in Sweden." 

IGN links researchers needing large-scale, whole human genome sequencing with world class institutions that provide this service, and delivers unmatched access to the highest quality of whole genome sequencing data. All IGN partners are experienced and well-published using Illumina's next-generation sequencing technology, and have completed Illumina's Certified Service Provider (CSPro) certification. Each possesses ten or more Illumina high-throughput sequencing systems, providing the scalability to handle large sequencing projects with rapid completion times. 

SciLifeLab joins twelve other IGN partners who provide a full range of WGS services: 

British Columbia Cancer Agency in Vancouver, Canada 

The Broad Institute in Cambridge, Massachusetts 

Cold Spring Harbor Laboratory in Cold Spring Harbor, New York 

HudsonAlpha Institute for Biotechnology in Huntsville, Alabama 

Macrogen & Genomic Medicine Institute in Seoul, Korea 

McGill University in Montreal, Canada 

National Center for Genome Resources in Santa Fe, New Mexico 

New York Genome Center in New York, New York 

Northwest Genomics Center at University of Washington in Seattle, Washington 

Peking University in Beijing, China 

Takara Bio, Shiga, Japan 

Illumina's FastTrack Services lab in San Diego, California 

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Illumina Files Patent Infringement Suit Against Premaitha
Patent infringement suit filed in the United Kingdom against Premaitha Health plc for infringement of NIPT patents.
Monday, March 16, 2015
Illumina to Provide NGS Technologies to Quest Diagnostics
The multi-year licensing agreement is related to the use of Illumina's next-generation sequencing technology for clinical laboratory testing.
Thursday, January 09, 2014
Illumina Reports Record Financial Results for Fourth Quarter and Fiscal Year 2012
Revenue of $309 million, a 24% increase compared to $250 million in the fourth quarter of 2011.
Tuesday, January 29, 2013
Illumina Names Dr. Robert S. Epstein to its Board of Directors
Dr. Epstein has worked in public health and academia before joining the private sector.
Monday, December 03, 2012
Caris Life Sciences Selects Illumina’s MiSeq® System
Collaboration enhances breadth and depth of therapeutic information to help oncologists better personalize cancer treatment.
Friday, November 09, 2012
Illumina and Wellcome Trust Sanger Institute Announce Completed Genome for Endangered Tasmanian Devil
Uncovering mutations found in deadly transmissible cancer could help conservation efforts.
Monday, September 20, 2010
Genomic Medicine Institute Adds Seven Additional Illumina Genome Analyzers
Acquisition expands the capacity of GMI’s recently established Asian Genome Center to 10 Illumina sequencing systems.
Thursday, July 23, 2009
Illumina Announces Personal Genome Sequencing Service
Company has unveiled a service program to provide high-quality personal genome sequencing for consumers.
Friday, June 12, 2009
Illumina Introduces Three new Research Products to Study Genetic Variations Linked to Cancer Development
The expansion will enable profiling of cancer’s unique gene expression and methylation signatures.
Saturday, April 12, 2008
Illumina Sequences the First African Human Genome
Accomplishment marks a significant milestone enabling economical human genome resequencing.
Thursday, February 07, 2008
Illumina Collaborates with Clinical Research Institute to Develop Molecular Diagnostics for Complex Diseases
The agreement recognizes Illumina’s technology and development expertise with Mayo Clinic’s utility to establish new diagnostic technologies.
Wednesday, January 10, 2007
Illumina Genotyping Solutions to Support Study of Inflammatory Bowel Disease
NIDDK1 IBD Genetics Consortium will utilize the Sentrix® HumanHap300 BeadChips and Infinium™ assay reagents.
Saturday, January 14, 2006
Illumina Advances Genetic Analysis of Cancer
Illumina is launching software tools that enable customers to use Infinium™ SNP genotyping data.
Friday, December 16, 2005
Illumina to Conduct Large-Scale Genotyping Study
Study Designed to Understand Genetic Susceptibility, Mechanisms of Disease Progression, and Cancer Therapy Management.
Wednesday, November 09, 2005
Parc Team Purchases Illumina Genotyping Solutions
Illumina to provide Children's Hospital Oakland Research Institute with reagents and instrumentation.
Friday, October 21, 2005
Scientific News
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Mathematical Model Forecasts the Path of Breast Cancer
Chances of survival depend on which organs breast cancer tumors colonize first.
Ancient Viral Molecules Essential for Human Development
Genetic material from ancient viral infections is critical to human development, according to researchers at the Stanford University School of Medicine.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Personalized Drug Screening for Multiple Myeloma Patients
A personalized method for testing the effectiveness of drugs that treat multiple myeloma may predict quickly and more accurately the best treatments for individual patients with the bone marrow cancer.
Metabolic Profiles Distinguish Early Stage Ovarian Cancer with Unprecedented Accuracy
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
New Way to Force Stem Cells to Become Bone Cells
Potential therapies based on this discovery could help people heal bone injuries or set hardware, such as replacement knees and hips.
Promise of Newborn Stem Cells to Revolutionize Clinical Practice
In this article Shweta Sharma, PhD, discusses the potential of an Umbilical Cord Blood bank as an untapped source of samples for research and clinical trials.
New Anti-Malarial Drug Screening Model
University of South Florida researchers demonstrate novel chemogenomic profiling to identify drug targets for the most lethal strain of malaria.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos